Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001171843-22-004065
Filing Date
2022-06-01
Accepted
2022-06-01 12:02:07
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFR14A defr14a_053122.htm DEFR14A 25792
2 GRAPHIC logo.jpg GRAPHIC 3552
  Complete submission text file 0001171843-22-004065.txt   31960
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

EIN.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 001-14027 | Film No.: 22986577
SIC: 3841 Surgical & Medical Instruments & Apparatus